Entera BioENTX
13F holders, Q2 2024 (June 30)15holders
5new positions
5sold out
1famous investor
$1.84avg. 13F price*
At the end of Q2 2024, 15 institutions reported holding Entera Bio Ltd. (ENTX) in their 13F filings, unchanged from Q1 2024. 5 opened new positions and 5 sold out. The largest holders were Knoll Capital Management, LLC ($7.1M), Schonfeld Strategic Advisors LLC ($1.2M) and Parkman Healthcare Partners LLC ($739K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Entera Bio Ltd.
- CUSIP
- M40527109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2.0M |
| Exits | 5 | $95K |
All 13F filers, Q1 2024 → Q2 2024: 1,130,807 shares bought and 97,161 shares sold, net +1,033,646 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Knoll Capital Management, LLC | 4.81% | No change | 3,881,879 | $7.1M |
| Schonfeld Strategic Advisors LLC | 0.01% | New | 671,758 | $1.2M |
| Parkman Healthcare Partners LLC | 0.10% | New | 401,518 | $739K |
| UBS Group AG | 0.00% | Add +11.8% | 167,623 | $308K |
| Renaissance Technologies | 0.00% | Reduce -23.1% | 57,600 | $106K |
| Susquehanna International Group, LLP | 0.00% | Reduce -44.1% | 28,856 | $53K |
| Osaic Holdings, Inc. | 0.00% | Add +1018.5% | 16,777 | $37K |
| Geode Capital Management, LLC | 0.00% | No change | 17,597 | $32K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 13,000 | $24K |
| Cibc World Market Inc. | 0.00% | New | 12,500 | $23K |
| HighTower Advisors, LLC | 0.00% | No change | 11,830 | $22K |
| NewEdge Advisors, LLC | 0.00% | New | 9,000 | $17K |
| Bank of America Corp. | 0.00% | New | 3,000 | $6K |
| Group One Trading LLC | 0.00% | No change | 51 | $94 |
| Simplex Trading, LLC | 0.00% | Reduce -11.9% | 260 | $0 |
"% of holder's portfolio" is ENTX's weight in each manager's 13F, not the share of Entera Bio Ltd. the manager owns.